ZA733138B - Stabilization of ahf - Google Patents

Stabilization of ahf

Info

Publication number
ZA733138B
ZA733138B ZA733138A ZA733138A ZA733138B ZA 733138 B ZA733138 B ZA 733138B ZA 733138 A ZA733138 A ZA 733138A ZA 733138 A ZA733138 A ZA 733138A ZA 733138 B ZA733138 B ZA 733138B
Authority
ZA
South Africa
Prior art keywords
ahf
stabilization
Prior art date
Application number
ZA733138A
Other languages
English (en)
Inventor
L Fekete
S Holst
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of ZA733138B publication Critical patent/ZA733138B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Golf Clubs (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
ZA733138A 1972-05-17 1973-05-09 Stabilization of ahf ZA733138B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (1)

Publication Number Publication Date
ZA733138B true ZA733138B (en) 1974-03-27

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA733138A ZA733138B (en) 1972-05-17 1973-05-09 Stabilization of ahf

Country Status (18)

Country Link
US (2) US3803115A (fr)
JP (1) JPS596845B2 (fr)
AT (1) AT344881B (fr)
AU (1) AU465351B2 (fr)
BE (1) BE799525A (fr)
CA (1) CA1007986A (fr)
CH (1) CH630804A5 (fr)
DE (1) DE2324717C3 (fr)
DK (1) DK136016B (fr)
ES (1) ES414823A1 (fr)
FR (1) FR2184898B1 (fr)
GB (1) GB1372515A (fr)
IL (1) IL42221A (fr)
IT (1) IT1061433B (fr)
NL (1) NL7306806A (fr)
NO (1) NO142381C (fr)
SE (1) SE430020B (fr)
ZA (1) ZA733138B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1074698A (fr) * 1977-12-19 1980-04-01 Gail A. Rock Methode pour augmenter la production de facteur antihemophilique viii dans le sang et le plasma
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
DE3163003D1 (en) * 1980-01-18 1984-05-17 Canadian Red Cross Method of obtaining factor viii
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (fr) * 1981-10-01 1984-12-04 Gail A. Rock Concentres de facteur viii prepares a partir de plasma heparinise grace a une technique de precipitation a froid
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3684459D1 (de) * 1986-03-27 1992-04-23 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
EP1363616A1 (fr) * 2001-02-07 2003-11-26 Shanbrom Technologies, LLC Acide carboxylique, par exemple acide citrique, utilise pour la desinfection ou l'amelioration de la production de produits sanguins, tels que le plasma, le cryoprecipite et/ou les plaquettes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (de) 1966-05-07 1966-11-10 Braun Fa B Bohrdraht-bereitschaftskasten.
BE713764A (fr) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Also Published As

Publication number Publication date
JPS4956695A (fr) 1974-06-01
IL42221A0 (en) 1973-07-30
CH630804A5 (de) 1982-07-15
AU5584973A (en) 1974-11-21
SE430020B (sv) 1983-10-17
DE2324717B2 (de) 1980-01-03
IL42221A (en) 1977-04-29
NL7306806A (fr) 1973-11-20
USRE29698E (en) 1978-07-11
ES414823A1 (es) 1976-02-01
BE799525A (fr) 1973-08-31
DK136016B (da) 1977-08-01
DK136016C (fr) 1978-01-02
ATA433573A (de) 1975-04-15
US3803115A (en) 1974-04-09
AT344881B (de) 1978-08-10
AU465351B2 (en) 1975-09-25
JPS596845B2 (ja) 1984-02-15
NO142381C (no) 1980-08-13
GB1372515A (en) 1974-10-30
IT1061433B (it) 1983-02-28
DE2324717A1 (de) 1973-12-13
FR2184898A1 (fr) 1973-12-28
CA1007986A (en) 1977-04-05
NO142381B (no) 1980-05-05
DE2324717C3 (de) 1983-12-01
FR2184898B1 (fr) 1976-11-05

Similar Documents

Publication Publication Date Title
GB1372515A (en) Stabilization of ahf
ZA734037B (en) Compounds of the androstane series having anaesthetic activity
AU6198173A (en) Manufacture of insulin
JPS56131569A (en) Manufacture of aminonicotinonitrile
ZA71586B (en) Treatment of brine
ZA738066B (en) Methods of disinfection
ZA722862B (en) Treatment of gaseous effluent
ZA722132B (en) Stabilisation of peroxy-materials
CA995205A (en) Stabilization of iron catalysts
JPS5444657A (en) Manufacture of silylester of azetidinee22sulfenate
ZA738284B (en) Manufacture of t-butanol
JPS5699460A (en) Manufacture of 2*66diaminoodihydropyridines
ZM673A1 (en) Chemosterilisation of ixodides
CA859115A (en) Stabilization of catalase
CA911886A (en) Stabilization of oestrogen-sulphate
CA905976A (en) Stabilization of propiolactones
CA1010387A (en) Stabilization of vodka
JPS55102569A (en) Manufacture of 11*22delta22imidazolinyl** 2*22diarylcyclopropane
CA851232A (en) Stabilization of alkylidenebicycloheptenes
ZA734036B (en) Compounds of the androstane series having anaesthetic activity
IL43151A0 (en) The manufacture of modified saturated alkyds
CA943142A (en) Stabilization of methylchloroform
CA853762A (en) Treatment of aqueous material
CA933719A (en) Treatment of microporous material
AU440967B2 (en) Treatment of microporous material